Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
MagIA diagnostics logo — Your immunoassay: Faster, Simpler, Accessible

MagIA diagnostics

Your immunoassay: Faster, Simpler, Accessible

Founded 2017 France France 18 employees Seed Total: $2.45M Biotechnology

General Information

Company Name MagIA diagnostics
Founded Year 2017
Location France France
Employees 18
Industries Biotechnology
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with MagIA diagnostics. To contact MagIA diagnostics, visit magia-diagnostics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About MagIA diagnostics

MagIA diagnostics is a biotechnology startup based in France, founded in 2017. The company's slogan, "Your immunoassay: Faster, Simpler, Accessible," reflects its goal to develop a multi-analysis "Point-of-Care" system for rapid and accessible diagnostics outside of traditional clinical settings. With a primary focus on infectious diseases, MagIA aims to provide syndromic testing at the point of care, initially targeting the rapid detection of infectious diseases, such as HIV and Viral Hepatitis, particularly in high-risk populations. Their innovative one-step, no-wash immunoassay method offers laboratory-quality analyses on a portable device, allowing for indoor and outdoor use. The company recently secured a significant €1.15M Seed Round investment on 15th January 2025 to further its development and expansion efforts. MagIA's unique approach and technology have positioned it as a promising player in the field of rapid diagnostics.

Taxonomy: Point-of-Care Testing, Infectious Diseases, Immunoassay, Syndromic Testing, Rapid Screening, Multiparameter Testing, Diagnostic Devices, High-Risk Populations

Services & Products

Development and manufacturing of in-vitro diagnostic products for life sciences industry

Target Customers

Clinical laboratories healthcare facilities researchers in the life sciences industry

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round €1.15M -
15 Jan 2025
Seed Round €1.30M -
24 Jul 2020

MagIA diagnostics Alternatives & Competitors

MagIA diagnostics vs
Applied BioCode, Inc.
Applied BioCode, Inc. United States

The Ideal Choice for Cost-Effective High Throughput Syndromic Panels

Venture round
60 employees
Biotechnology, Health Care
MagIA diagnostics vs
QuikPath
QuikPath Singapore

Increasing access to diagnostics through rapid, easy-to-use, and affordable isothermal RT-PCR point-...

1 employees
Biotechnology
MagIA diagnostics vs
Premier Medical Corporation Private Limited
Premier Medical Corporation Private Limited India

Commitment to Quality and Care

82 employees
Biotechnology, Hardware
Compare MagIA diagnostics vs Premier Medical Corporation Private Limited

FAQ About MagIA diagnostics

Your immunoassay: Faster, Simpler, Accessible
MagIA diagnostics was founded in 2017.
MagIA diagnostics is headquartered in France.
MagIA diagnostics operates in Biotechnology. Its work centres on Point-of-Care Testing, Infectious Diseases, Immunoassay and Syndromic Testing. Its customers include Clinical laboratories, healthcare facilities and researchers in the life sciences industry.
MagIA diagnostics has approximately 18 employees.
MagIA diagnostics has completed 2 funding rounds, raising a total of $2.45M. The latest funding stage is Seed.
MagIA diagnostics offers: Development and manufacturing of in-vitro diagnostic products for life sciences industry.
Top alternatives and competitors to MagIA diagnostics include Applied BioCode, Inc., QuikPath, Premier Medical Corporation Private Limited, Droplite, Lucira Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MagIA diagnostics and Applied BioCode, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for MagIA diagnostics, https://bouncewatch.com/company/magia-diagnostics, updated 11 June 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes